Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Assertio: Q4 Earnings Snapshot

Assertio: Q4 Earnings Snapshot

ASRT : 0.7223 (+0.25%)
Assertio Reports Fourth Quarter and Full Year 2024 Financial Results

ASRT : 0.7223 (+0.25%)
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

ASRT : 0.7223 (+0.25%)
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ASRT : 0.7223 (+0.25%)
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

ASRT : 0.7223 (+0.25%)
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study

ASRT : 0.7223 (+0.25%)
Assertio Holdings Appoints Paul Schwichtenberg as Chief Transformation Officer and Mary Pietryga as Chief Commercial Officer

Assertio Holdings creates a Transformation Office, appointing Paul Schwichtenberg as Chief Transformation Officer, and Mary Pietryga as Chief Commercial Officer.Quiver AI SummaryAssertio Holdings, Inc....

ASRT : 0.7223 (+0.25%)
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO

ASRT : 0.7223 (+0.25%)
New Strong Buy Stocks for November 29th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Makita Corporation MKTAY: This tools and equipment manufacturing company has seen the Zacks Consensus Estimate for its current year...

CHH : 130.28 (+1.87%)
DRS : 32.23 (+2.81%)
ASRT : 0.7223 (+0.25%)
MKTAY : 35.3300 (+0.17%)
BRKL : 10.93 (+1.96%)
Assertio: Q3 Earnings Snapshot

Assertio: Q3 Earnings Snapshot

ASRT : 0.7223 (+0.25%)

Barchart Exclusives

3 High-Yield Dividend Aristocrats Worth Buying To Survive a Recession
These three Dividend Aristocrats care about profitability, predictable dividend growth, and sustainable payout ratios for their income investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar